The Atlas will enable the validation of genetic targets and training of AI models at unprecedented scale SAN DIEGO, Jan. 13, ...
Tempus, a leader in artificial intelligence and precision medicine, and NYU Langone Health, one of the nation’s premier ...
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
Explore how multi-angle light scattering enhances biosimilar analysis by delivering accurate molecular weight and size ...
NeuroScientific Biopharmaceuticals’ stem cell tech has delivered real-world promise for those with Crohn’s disease, ...
Flooss, a Bahrain-based Sharia-compliant fintech, has secured a $22 million credit facility structured by Shorooq, ...
The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...
Vancouver, B.C. – Jan 8, 2026 ‐ TheNewswire - Forty Pillars Mining Corp. (CSE: PLLR) (the “Company” or “Forty Pillars”) is ...
The Daily Overview on MSN
Nvidia teams with biotech giants to supercharge AI drug discovery
Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with ...
CES 2026 concluded as the largest post-pandemic edition of the world’s most powerful tech event, drawing more than 148,000 attendees—including over 55,000 international visitors and 6,900 media ...
Months after announcing a new program to validate self-reported nursing home quality data, the Centers for Medicare & Medicaid Services has begun notifying providers of their selection.
We believe this recognition from the IDC MarketScape validates our approach to solving one of healthcare's most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results